Ligandrol – LGD-4033 10mg
Ligandrol is presented in the ORYVION catalog as a tablet formulation containing 10mg of LGD-4033 per tablet, supplied in containers of 50 tablets. LGD-4033 is an investigational, orally active, nonsteroidal selective androgen receptor modulator (SARM).
Its mechanism of action involves binding to androgen receptors and influencing androgen-dependent signaling. Early clinical research has examined its effects on lean body mass, muscle strength, and hormonal regulation. A short placebo-controlled study observed increased lean body mass alongside suppression of testosterone and reductions in HDL cholesterol. These findings do not establish long-term safety or effectiveness for athletic performance.
Product Specifications:
Commercial name: Ligandrol
Listed compound: LGD-4033
Declared strength: 10mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
LGD-4033 can suppress testosterone levels and adversely affect cholesterol. Serious liver injury has been reported with SARM-containing products, and potential cardiovascular risks remain a concern.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.